Effects of liposomal prostaglandin E1 on periprocedural myocardial injury in patients with unstable angina undergoing an elective percutaneous coronary intervention.

作者: Yanming Fan , Yunfa Jiang , Xianghua Fu , Junna Cai , Yanbo Wang

DOI: 10.1097/MCA.0000000000000294

关键词:

摘要: … Department of the Second Hospital of Hebei Medical University. The definition of UA … of the Second Hospital of Hebei Medical University. Written informed consent was obtained …

参考文章(35)
Atul Aggarwal, David J Schneider, Edward F. Terrien, Kristin E. Gilbert, Harold L. Dauerman, Increase in Interleukin-6 in the First Hour after Coronary Stenting: An Early Marker of the Inflammatory Response Journal of Thrombosis and Thrombolysis. ,vol. 15, pp. 25- 31 ,(2003) , 10.1023/A:1026188200939
Guo-Zhen Hao, Wei-Ze Fan, Xin-Shun Gu, Xiang-Hua Fu, Shi-Qiang Li, Wei-Li Wu, Xin-Wei Jia, Yun-Fa Jiang, Jing Zhang, Intensive cholesterol lowering with statin improves the outcomes of percutaneous coronary intervention in patients with acute coronary syndrome. Chinese Medical Journal. ,vol. 122, pp. 659- 664 ,(2009)
Joseph B. Selvanayagam, Italo Porto, Keith Channon, Steffen E. Petersen, Jane M. Francis, Stefan Neubauer, Adrian P. Banning, Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. ,vol. 111, pp. 1027- 1032 ,(2005) , 10.1161/01.CIR.0000156328.28485.AD
Hiroshi Akahori, Toshinari Takamura, Tetsuo Hayakawa, Hitoshi Ando, Haruhisa Yamashita, Ken-ichi Kobayashi, Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality. Diabetes Research and Clinical Practice. ,vol. 64, pp. 153- 159 ,(2004) , 10.1016/J.DIABRES.2003.10.012
Richard V. Milani, Robert Fitzgerald, Jenna N. Milani, Carl J. Lavie, The impact of micro troponin leak on long-term outcomes following elective percutaneous coronary intervention. Catheterization and Cardiovascular Interventions. ,vol. 74, pp. 819- 822 ,(2009) , 10.1002/CCD.22160
Igor Huk, Viktor Brovkovych, Joseph Nanobashvili, Christoph Neumayer, Peter Polterauer, Manfred Prager, Stephen Patton, Tadeusz Malinski, Prostaglandin E1 reduces ischemia/reperfusion injury by normalizing nitric oxide and superoxide release. Shock. ,vol. 14, pp. 234- 242 ,(2000) , 10.1097/00024382-200014020-00026
P. Scheffler, J. Gross, T. Markwirth, J. Maier, H. Schieffer, Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1). European Journal of Clinical Pharmacology. ,vol. 51, pp. 235- 239 ,(1996) , 10.1007/S002280050190
Takae Kawamura, Noriko Nara, Mamoru Kadosaki, Katsuya Inada, Shigeatu Endo, Prostaglandin E1 reduces myocardial reperfusion injury by inhibiting proinflammatory cytokines production during cardiac surgery. Critical Care Medicine. ,vol. 28, pp. 2201- 2208 ,(2000) , 10.1097/00003246-200007000-00004